BioCryst says oral drug works for HAE attacks

September 04, 2018

By: Phil Taylor

BioCryst Pharma says its oral drug BCX7353 was effective in treating acute hereditary angioedema (HAE) attacks in a midstage trial, setting up a possible registration…